Related Experiment Video
Updated: Aug 16, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Endurance training reduces circulating inflammatory markers in persons at risk of coronary events: impact on plaque
Alexander Niessner1, Bernhard Richter, Martina Penka
1Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria. alexander.niessner@meduniwien.ac.at
Insights
Endurance training significantly reduces inflammatory markers like IL-8 and MMP-9 in individuals with coronary artery disease (CAD). This effect is more pronounced in diabetic patients and those on statin therapy, suggesting benefits for cardiovascular health.
Area of Science:
- Cardiovascular Disease Research
- Exercise Physiology
- Inflammation Biology
Background:
- Inflammatory pathways play a crucial role in the destabilization of atherosclerotic plaques.
- Understanding the impact of exercise on inflammatory markers is vital for managing cardiovascular disease (CAD).
Purpose of the Study:
- To investigate the effect of a 12-week supervised endurance training program on circulating inflammatory markers in individuals with CAD and/or cardiovascular risk factors (CVRFs).
- To assess whether diabetes mellitus (DM) or statin use influences the changes in inflammatory markers in response to endurance training.
Main Methods:
- Thirty-two subjects with CAD and/or CVRFs participated in a 12-week supervised endurance training program.
- Circulating concentrations of chemokines (interleukin-8, monocyte chemoattractant protein-1), matrix metalloproteinase-9 (MMP-9), and acute phase reactants (interleukin-6, high-sensitivity C-reactive protein) were measured before and after training.
- Statistical analyses were performed to determine significant changes and the influence of factors like DM and statin use.
Main Results:
- Endurance training led to significant decreases in interleukin-8 (IL-8) by 21% and monocyte chemoattractant protein-1 (MCP-1) by 5%.
- Matrix metalloproteinase-9 (MMP-9) significantly decreased by 18% following the training program.
- The reduction in IL-8 was significantly greater in diabetic patients (39% decrease), and MMP-9 reduction was more pronounced in patients taking statins (44% decrease).
- No significant changes were observed in interleukin-6 (IL-6) or high-sensitivity C-reactive protein (hs-CRP).
Conclusions:
- Endurance training effectively reduces circulating levels of key inflammatory chemokines and MMP-9 in individuals with CAD and CVRFs.
- These reductions may contribute to the beneficial effects of endurance training on coronary risk.
- Patients with DM and those on statin therapy may experience particularly significant benefits from endurance training regarding these inflammatory markers.
Abstract:
Inflammatory pathways are involved in destabilization of atherosclerotic plaques. We assessed the hypothesis that endurance training decreases circulating concentrations of inflammatory markers in persons with coronary artery disease (CAD) and cardiovascular risk factors (CVRFs). Thirty-two subjects with CAD and/or CVRFs joined a 12-week supervised endurance training. We found a significant decrease of the chemokines interleukin (IL)-8 (pre: 3.9+/-0.6, change: -1.2+/-0.4 pg/ml, -21%, p=0.002) and monocyte chemoattractant protein-1 (pre: 213+/-9, change: -20.4+/-8.2 pg/ml, -5%, p=0.03). Diabetes mellitus (DM) significantly influenced changes of IL-8 (p=0.002). IL-8 substantially dropped by 39% in diabetics. Moreover, matrix metalloproteinase-9 (MMP-9) highly significantly decreased in response to training (pre: 750+/-98, change: -278+/-77 ng/ml, -18%, p=0.005). Exercise-induced changes of MMP-9 were influenced by concomitant use of statins (p=0.038). We observed a particularly strong MMP-9 reduction of 44% in patients treated with statins. Acute phase reactants IL-6 (pre: 1.7+/-0.3, change: +0.25+/-0.7 pg/ml, +4%, p=0.58) and high sensitivity C-reactive protein (pre: 2.1+/-0.5, change: -0.25+/-0.4 mg/l, -9%, p=0.54) did not change in response to training. In conclusion, endurance training decreased circulating chemokines and MMP-9, which may in part explain its beneficial effect on coronary risk. Patients with DM or treated with statins because of hypercholesterolemia may particularly take advantage.
Related Concept Videos
Atherosclerosis III: Management
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease I: Introduction
Inflammation
Peripheral Artery Disease III: Interprofessional Care
